Evidence map›Paper›PMID 41180347›Full record

ArticleCJC open2025

Pharmacologic Profile of A

Pierre Deharo, Julien Fromonot, Soumeya Aliouane, Marion Marlinge, Bouchra Talbi, Nathalie Kipson, Tristan Werquin, Julia Dodivers, Thomas Cuisset, Marine Gaudry and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CJC open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pierre DeharoCardiology Department, Timone University Hospital, Marseille, France.
Julien FromonotCentre for Cardiovascular and Nutrition Research, INSERM (French National Institute of Health and Medical Research), INRAE (French National Research Institute for Agriculture, Food, and Environment), Aix Marseille University, Marseille, France.
Soumeya AliouaneCardiology Department, Timone University Hospital, Marseille, France.
Marion MarlingeCentre for Cardiovascular and Nutrition Research, INSERM (French National Institute of Health and Medical Research), INRAE (French National Research Institute for Agriculture, Food, and Environment), Aix Marseille University, Marseille, France.
Bouchra TalbiLaboratory of Biochemistry, Marseille University Hospital (AP-HM), Marseille, France.
Nathalie KipsonCentre for Cardiovascular and Nutrition Research, INSERM (French National Institute of Health and Medical Research), INRAE (French National Research Institute for Agriculture, Food, and Environment), Aix Marseille University, Marseille, France.
Tristan WerquinCentre for Cardiovascular and Nutrition Research, INSERM (French National Institute of Health and Medical Research), INRAE (French National Research Institute for Agriculture, Food, and Environment), Aix Marseille University, Marseille, France.
Julia DodiversCentre for Cardiovascular and Nutrition Research, INSERM (French National Institute of Health and Medical Research), INRAE (French National Research Institute for Agriculture, Food, and Environment), Aix Marseille University, Marseille, France.
Thomas CuissetCardiology Department, Timone University Hospital, Marseille, France.
Marine GaudryDepartment of Vascular Surgery, Timone University Hospital, Marseille, France.
Régis GuieuCentre for Cardiovascular and Nutrition Research, INSERM (French National Institute of Health and Medical Research), INRAE (French National Research Institute for Agriculture, Food, and Environment), Aix Marseille University, Marseille, France.
Franck PaganelliCentre for Cardiovascular and Nutrition Research, INSERM (French National Institute of Health and Medical Research), INRAE (French National Research Institute for Agriculture, Food, and Environment), Aix Marseille University, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-extremity peripheral artery disease (LE-PAD) is often associated with coronary artery disease (CAD). Development of biomarkers is needed to identify those among LE-PAD patients who have associated CAD. The pharmacologic profile of adenosine A

Indexed as

adenosine A2A receptorsbiological markersintermittent claudicationmyocardial ischemia

Identifiers

PMID41180347
PMCPMC12572863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.